Market revenue in 2023 | USD 42.9 million |
Market revenue in 2030 | USD 57.2 million |
Growth rate | 4.2% (CAGR from 2023 to 2030) |
Largest segment | Transvenous implantable cardioverter-defibrillators |
Fastest growing segment | Subcutaneous Implantable Cardioverter Defibrillators |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Transvenous Implantable Cardioverter-Defibrillators, Subcutaneous Implantable Cardioverter Defibrillators |
Key market players worldwide | Abbott Laboratories, Medtronic PLC, BIOTRONIK, Boston Scientific Corp, MicroPort Scientific Corp, LivaNova PLC |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to implantable cardioverter defibrillators market will help companies and investors design strategic landscapes.
Transvenous implantable cardioverter-defibrillators was the largest segment with a revenue share of 89.28% in 2023. Horizon Databook has segmented the South Africa implantable cardioverter defibrillators market based on transvenous implantable cardioverter-defibrillators, subcutaneous implantable cardioverter defibrillators covering the revenue growth of each sub-segment from 2018 to 2030.
The ICD market in South Africa is witnessing significant growth due to the increasing burden of CVDs in the country. A study published in the Cardiovascular Journal of Africa in May 2021 revealed that five people suffer from a stroke every hour, and ten people experience a heart attack.
This alarming statistic emphasizes the need for advanced cardiac treatment options such as ICDs. The prevalence of obesity, which is a significant risk factor for CVDs, is also driving market growth. According to an article published by the South African Health Review in October 2021, the country’s population is estimated to be 57.3 million in 2021, with 8.3% of the population over 60 years.
The geriatric population is projected to increase by 15.4% of the total population by 2050. As the senior population is more susceptible to CVDs, the growth of this population segment in South Africa is expected to support the expansion of the ICDs market.
Horizon Databook provides a detailed overview of country-level data and insights on the South Africa implantable cardioverter defibrillators market , including forecasts for subscribers. This country databook contains high-level insights into South Africa implantable cardioverter defibrillators market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account